Breaking News

Thomas Lee Partners, Frazier Healthcare Acquires Adare Pharmaceuticals

Includes Adare’s CDMO, pharmaceutical technology and microbiome businesses; will rebrand as Adare Pharma Solutions.

By: Contract Pharma

Contract Pharma Staff

Thomas H. Lee Partners (THL) and Frazier Healthcare Partners have acquired Adare Pharmaceuticals, which will be rebranded Adare Pharma Solutions, a specialty contract development and manufacturing organization (CDMO) and global provider of advanced pharmaceutical technologies, from TPG Capital. The acquisition includes Adare’s CDMO, pharmaceutical technology and microbiome businesses. TPG Capital will retain rights to Adare’s Eosinophilic Esophagitis (EoE) product, which has been spun out into a...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters